Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04777266
Other study ID # StateReferenceCenter
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date April 30, 2019

Study information

Verified date May 2023
Source State reference center for psychosocial care
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Treatment of symptoms, rehabilitation of cognitive deficits, improvement of social functioning and quality of life in schizophrenia and other psychoses are approached through a comprehensive strategy that combines psychopharmacology with psychosocial interventions. However, despite the efficacy of these interventions, this is not the same in all patients, and a large percentage do not achieve functional recovery.


Description:

The aim of this research is to carry out a randomized trial on the effects of a music therapy (MT) program, implemented in addition to the usual pharmacological and psychosocial rehabilitation (TAU), on symptoms, self-esteem, internalized stigma, social cognition, social functioning and the quality of life in these patients.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 30, 2019
Est. primary completion date April 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - The patients will be diagnosed with schizophrenia or schizoaffective disorder in accordance with DSM-IV-TR criteria using the Structured Clinical Interview for DSM-IV-TR (SCID-I). - The patients will all clinically stable with a diagnosis of schizophrenia and regularly attended in the state approved centre for psychosocial attention CREAP (Centro de Referencia Estatal para la AtenciĆ³n Psicosocial) in Valencia (Spain). Exclusion Criteria: - Previous brain damage - Substance abuse in the last year - Display of mood disorders - Organic or substance based mental disorders - Disrupted symptomatology - Serious symptoms with difficulty in understanding the implications of informed consent and not replying in the interviews and assessment questionnaires

Study Design


Intervention

Behavioral:
Music therapy and treatment as usual
The session-based intervention programme was designed with an integrated and multimodal perspective of music therapy [37], which allows the combination of active and passive activities together with focuses and perspectives based on empirical evidence [38]. It was implemented using a process-based approach, adapting content to different phases in the process: initial contact, managing resistance, confidence building, relationships, awareness, and closure. The central focus is on the patient and to adapt and remain flexible in the sessions in accordance with the capabilities and needs of the group members. Different perspectives are integrated via nonverbal communication. The layout and any changes to the setting are made in a gradual way in keeping with the process to foster feelings of security and belonging. Sessions begin with a brief period of breathing which then moves into warming-up and free-expression using instruments, followed by the central activity and the closure.

Locations

Country Name City State
Spain Sergio Lacamara Cano Valencia

Sponsors (2)

Lead Sponsor Collaborator
State reference center for psychosocial care University of Valencia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Positive and Negative Syndrome Scale (PANSS) Symptoms of schizophrenia are measured according to the subscale scores and total score on the PANSS which consists of 30 items scored from 1 (Absent) to 7 (Extreme). Scores range from 30 to 210, with higher scores indicating more symptoms. 10 weeks
Primary State-Trait Anxiety Inventory (STAI) The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic.Scores range from 20 to 80, with higher scores correlating with greater anxiety. 10 weeks
Primary World Health Organization Quality of Life-Short version (WHOQOL-BREF) The WHOQOL-BREF contains 24 questions covering 4 domains plus two questions related to overall quality of life and satisfaction with health. Highes scores represent higher quality of life. 10 weeks
See also
  Status Clinical Trial Phase
Completed NCT04559529 - Pharmacological Modulation of Hippocampal Activity in Psychosis 2 Phase 2
Recruiting NCT06134661 - Accelerated rTMS for Psychomotor Slowing N/A
Completed NCT05759091 - Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With Schizophrenia N/A
Not yet recruiting NCT05995457 - The IM-ZBULLE Study : " Z-track " and " Airlock " Techniques During Intramuscular Injection of Haloperidol Decanoate N/A
Not yet recruiting NCT06341517 - Brain Circuitry Therapeutics for Schizophrenia N/A
Not yet recruiting NCT05550155 - Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations N/A
Terminated NCT04277936 - Pharmacologic Modulation of Hippocampal Activity in Psychosis Phase 2
Active, not recruiting NCT04748679 - Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs N/A
Recruiting NCT05858255 - Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study N/A
Not yet recruiting NCT05763966 - Uppsala Psychosis Cohort
Not yet recruiting NCT05731414 - Outcomes From Remediation and Behavioural Intervention Techniques N/A
Completed NCT04898270 - Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients Phase 4
Completed NCT04659161 - A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) Phase 3
Completed NCT04260763 - Evaluating a Novel Mobile App for Social Cognition in Psychosis N/A
Recruiting NCT04853485 - Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes N/A
Completed NCT04738123 - A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) Phase 3
Recruiting NCT05445180 - Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use N/A
Not yet recruiting NCT06375902 - The Fragility of Metaphors (FraMe): Learning, Loosing, and How to Train Them
Completed NCT04773171 - Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia N/A